Insiders · Profile

Foresite Capital Management IV, LLC

10% owner at Eikon Therapeutics. Filing since 4 Feb 2026. CIK 0001704132

Company
Date
Role
Action
Shares
Amount
Of holding
4 Feb 2026
10% owner
Bought
55,555
$999.99K
4.4%
1 decision on file.